388 related articles for article (PubMed ID: 9316878)
1. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes.
Messina ES; Tyndale RF; Sellers EM
J Pharmacol Exp Ther; 1997 Sep; 282(3):1608-14. PubMed ID: 9316878
[TBL] [Abstract][Full Text] [Related]
2. Role of human cytochrome P4502A6 in C-oxidation of nicotine.
Nakajima M; Yamamoto T; Nunoya K; Yokoi T; Nagashima K; Inoue K; Funae Y; Shimada N; Kamataki T; Kuroiwa Y
Drug Metab Dispos; 1996 Nov; 24(11):1212-7. PubMed ID: 8937855
[TBL] [Abstract][Full Text] [Related]
3. Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes.
Yamazaki H; Inoue K; Hashimoto M; Shimada T
Arch Toxicol; 1999 Mar; 73(2):65-70. PubMed ID: 10350185
[TBL] [Abstract][Full Text] [Related]
4. Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes.
Nakajima M; Yamamoto T; Nunoya K; Yokoi T; Nagashima K; Inoue K; Funae Y; Shimada N; Kamataki T; Kuroiwa Y
J Pharmacol Exp Ther; 1996 May; 277(2):1010-5. PubMed ID: 8627511
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of methyl tert-butyl ether and other gasoline ethers by human liver microsomes and heterologously expressed human cytochromes P450: identification of CYP2A6 as a major catalyst.
Hong JY; Wang YY; Bondoc FY; Lee M; Yang CS; Hu WY; Pan J
Toxicol Appl Pharmacol; 1999 Oct; 160(1):43-8. PubMed ID: 10502501
[TBL] [Abstract][Full Text] [Related]
6. CYP2A6 AND CYP2B6 are involved in nornicotine formation from nicotine in humans: interindividual differences in these contributions.
Yamanaka H; Nakajima M; Fukami T; Sakai H; Nakamura A; Katoh M; Takamiya M; Aoki Y; Yokoi T
Drug Metab Dispos; 2005 Dec; 33(12):1811-8. PubMed ID: 16135656
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro.
Zhang W; Kilicarslan T; Tyndale RF; Sellers EM
Drug Metab Dispos; 2001 Jun; 29(6):897-902. PubMed ID: 11353760
[TBL] [Abstract][Full Text] [Related]
8. Nicotine 5'-oxidation and methyl oxidation by P450 2A enzymes.
Murphy SE; Raulinaitis V; Brown KM
Drug Metab Dispos; 2005 Aug; 33(8):1166-73. PubMed ID: 15860657
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
Draper AJ; Madan A; Parkinson A
Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of neurotransmitters and steroids on human CYP2A6.
Higashi E; Nakajima M; Katoh M; Tokudome S; Yokoi T
Drug Metab Dispos; 2007 Apr; 35(4):508-14. PubMed ID: 17237153
[TBL] [Abstract][Full Text] [Related]
11. Human cytochrome P450 isozymes in metabolism and health effects of gasoline ethers.
Hong JY; Wang YY; Mohr SN; Bondoc FY; Deng C
Res Rep Health Eff Inst; 2001 May; (102):7-27; discussion 95-109. PubMed ID: 11504148
[TBL] [Abstract][Full Text] [Related]
12. (+)-cis-3,5-dimethyl-2-(3-pyridyl) thiazolidin-4-one hydrochloride (SM-12502) as a novel substrate for cytochrome P450 2A6 in human liver microsomes.
Nunoya K; Yokoi Y; Kimura K; Kodama T; Funayama M; Inoue K; Nagashima K; Funae Y; Shimada N; Green C; Kamataki T
J Pharmacol Exp Ther; 1996 May; 277(2):768-74. PubMed ID: 8627557
[TBL] [Abstract][Full Text] [Related]
13. Bioactivation of tegafur to 5-fluorouracil is catalyzed by cytochrome P-450 2A6 in human liver microsomes in vitro.
Ikeda K; Yoshisue K; Matsushima E; Nagayama S; Kobayashi K; Tyson CA; Chiba K; Kawaguchi Y
Clin Cancer Res; 2000 Nov; 6(11):4409-15. PubMed ID: 11106261
[TBL] [Abstract][Full Text] [Related]
14. Porcine CYP2A polymorphisms and activity.
Skaanild MT; Friis C
Basic Clin Pharmacol Toxicol; 2005 Aug; 97(2):115-21. PubMed ID: 15998359
[TBL] [Abstract][Full Text] [Related]
15. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans.
Nakajima M; Kwon JT; Tanaka N; Zenta T; Yamamoto Y; Yamamoto H; Yamazaki H; Yamamoto T; Kuroiwa Y; Yokoi T
Clin Pharmacol Ther; 2001 Jan; 69(1):72-8. PubMed ID: 11180041
[TBL] [Abstract][Full Text] [Related]
16. Characterization and comparison of nicotine and cotinine metabolism in vitro and in vivo in DBA/2 and C57BL/6 mice.
Siu EC; Tyndale RF
Mol Pharmacol; 2007 Mar; 71(3):826-34. PubMed ID: 17158199
[TBL] [Abstract][Full Text] [Related]
17. Depentylation of the rat esophageal carcinogen, methyl-n-pentylnitrosamine, by microsomes from various human and rat tissues and by cytochrome P450 2A3.
Chen SC; Zhou L; Ding X; Mirvish SS
Drug Metab Dispos; 2001 Sep; 29(9):1221-8. PubMed ID: 11502732
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human liver microsomal (S)-nicotine oxidation by (-)-menthol and analogues.
MacDougall JM; Fandrick K; Zhang X; Serafin SV; Cashman JR
Chem Res Toxicol; 2003 Aug; 16(8):988-93. PubMed ID: 12924926
[TBL] [Abstract][Full Text] [Related]
19. An inhibitory monoclonal antibody to human cytochrome P450 2A6 defines its role in the metabolism of coumarin, 7-ethoxycoumarin and 4-nitroanisole in human liver.
Sai Y; Yang TJ; Krausz KW; Gonzalez FJ; Gelboin HV
Pharmacogenetics; 1999 Apr; 9(2):229-37. PubMed ID: 10376770
[TBL] [Abstract][Full Text] [Related]
20. Comparison of CYP2A6 catalytic activity on coumarin 7-hydroxylation in human and monkey liver microsomes.
Li Y; Li NY; Sellers EM
Eur J Drug Metab Pharmacokinet; 1997; 22(4):295-304. PubMed ID: 9512924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
